Antidepressant Warnings On Pediatric Suicide Need Immediate Strengthening, Cmte. Says

A joint FDA advisory committee says suicide risk warnings should be communicated to physicians and consumers while the agency re-analyzes pediatric data from antidepressant manufacturers.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet